Anticoagulation in Patients with Dilated Cardiomyopathy, Low Ejection Fraction, and Sinus Rhythm: Back to the Drawing Board

Anticoagulation in Patients with Dilated Cardiomyopathy, Low Ejection Fraction, and Sinus Rhythm: Back to the Drawing Board

Summary Heart failure patients present an important thrombo‐embolic risk, including symptomatic or silent peripheral arterial embolism, pulmonary embolism, and stroke. Patients in sinus rhythm who have concomitant depressed (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular therapeutics 2013-10, Vol.31 (5), p.298-302
Hauptverfasser: Mischie, Alexandru Nicolae, Chioncel, Valentin, Droc, Ionel, Sinescu, Crina
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Anticoagulants - adverse effects
Apixaban
Biological and medical sciences
Cardiology. Vascular system
Cardiomyopathy, Dilated - complications
Cardiomyopathy, Dilated - drug therapy
Cardiomyopathy, Dilated - physiopathology
Cardiovascular system
Clinical Trials as Topic
Dabigatran
Dilated cardiomyopathy
Drug therapy
Embolisms
Fractions
Heart
Heart failure
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart Rate
Humans
Low ejection fraction <35
Medical sciences
Myocarditis. Cardiomyopathies
Pharmacology. Drug treatments
Rivaroxaban
Sinus rhythm
Stroke - epidemiology
Stroke Volume
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Heart failure patients present an important thrombo‐embolic risk, including symptomatic or silent peripheral arterial embolism, pulmonary embolism, and stroke. Patients in sinus rhythm who have concomitant depressed (
ISSN:1755-5914
1755-5922
DOI:10.1111/1755-5922.12019